Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Bute health risk to be assessed
EU agencies to advise on horse meat risks

Following the recent horse meat scandal, the European Commission has asked for an assessment on the risks of phenylbutazone (bute) to human health. Bute has been known to pose a risk to human health, and as a result its use in animals entering the food chain is prohibited.

The European Food Safety Authority (EFSA) and European Medicines Agency (EMA) are to carry out a joint assessment following the recent discovery of bute in a small number of horse carcasses intended for human consumption.

The two agencies will use all available scientific evidence, taking into account the results of ongoing horse meat testing in member states, as and when these become available.

In advising of any risk to consumers, the EFSA and EMA will consider the risks arising from consumption of horse meat, as well as the risks posed by products that have been illegally contaminated with horse meat. The agencies will also advise if additional control options are needed.

The EFSA and EMA will provide scientific advice to the European Commission by 15 April 2013. Their advice will be used to help inform decision making with regards to the recent findings.

Meanwhile, an overhaul of the horse passport system is expected in the next six months. Flaws in the system have been blamed for the presence of bute in horses meant for human consumption, and plans for an overhaul have been welcomed within the industry.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.